“IRIS International, a leading pharmaceutical business development firm since 2005, aims to provide high-quality and certified products to our clients in the healthcare sector. My core competencies include new business development, business planning, team building, and strong expertise in the pharmaceutical industry and market trends.I am proud to be a pioneer in Pakistan for developing the first combination of Anti-Malarial (Arte+ Lumefantrine) in 2005-6 and later the first generic of the Oral Hepatitis series, among many others, including Cephalosporins, Antibiotics, Vitamins, etc.IRIS International represents more than 30 global companies from around the world, with offices in Pakistan, China, India, and Dubai. We serve a clientele of 500 major multinational and local pharmaceutical firms, such as GSK, Pfizer, Sanofi, Merck, etc. We offer a wide range of products from trusted and certified sources worldwide, with WHO/EU-GMP and USFDA-approved facilities like Chemo, Shilpa, Fermenta, Qilu, Nectar, Productos Additos, etc. Our mission is to deliver excellence and satisfaction to our customers and partners, and to introduce innovative and effective products to the market.”